More on MGX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-61.8% Growth)
- Ratings (8.6 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Metagenomi (NQ:MGX)
Delayed: 0.81 -0.01 (1.22%)
Prev. Close $0.82  
Open$0.80 
52 Wk High$0.65 
52 Wk Low$0.65 
Day High$0.82 
Day Low$0.79 
P/E N/A  
EPS$0.00 
Volume76,731 

Friends, Peers and Foes (?): BEAM, CRSP, DTIL, EDIT, NTLA (more...)

Oct 13, 2026 08:00 AM Metagenomi Therapeutics, Inc. to Participate in the Chardan 10th Annual Healthcare Conference
Sep 22, 2026 06:02 AM Form 8-K Metagenomi Therapeutics, For: Sep 21
Sep 11, 2026 07:52 PM Form 4 Metagenomi Therapeutics, For: Sep 09 Filed by: Reid Laurence
Sep 10, 2026 04:05 PM Form SCHEDULE 13G Metagenomi Therapeutics, Filed by: Thomas Brian C.
Sep 10, 2026 03:47 PM Form 4 Metagenomi Therapeutics, For: Sep 08 Filed by: Wein Matthew
Sep 10, 2026 03:40 PM Form 4 Metagenomi Therapeutics, For: Sep 08 Filed by: Irish Jian
Sep 10, 2026 03:35 PM Form 4 Metagenomi Therapeutics, For: Sep 08 Filed by: Wapnick Pamela
Sep 1, 2026 08:00 AM Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
Aug 11, 2026 06:56 AM Metagenomi Inc (MGX) PT Lowered to $7 at Wells Fargo
Aug 10, 2026 06:23 PM Metagenomi, Inc. (MGX) Tops Q2 EPS by 5c
View All Articles

Entities mentioned with MGX

View All Entities